Explore 3 Stock Ideas & Industry Insights Download Free Report

blue-chip

Should You Consider These 2 Defensive US Stocks From Healthcare and Consumer Retail Sectors

Nov 20, 2026 | Team Kalkine
Should You Consider These 2 Defensive US Stocks From Healthcare and Consumer Retail Sectors
Image source: shutterstock

  • ELV:NYSE
  • Investment Type
    Large-cap
  • Risk Level
  • Action
  • Rec. Price (US$)

Company Overview: Elevance Health, Inc. (NYSE: ELV) operates as a health benefits company in the United States. It operates through 4 segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members.

Kalkine’s Daily Report covers the Investment Highlights, Key Financial Metrics, Risks, Outlook, Technical Analysis along with the Valuation, Target Price, and Recommendation on the stock.


Disclaimer-

The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.

Past performance is not a reliable indicator of future performance.

Support

Hi! How can we help you today?

Loading…